Effect of the Concomitant Use of Subcutaneous Basal Insulin and Intravenous Insulin Infusion in the Treatment of Severe Hyperglycemic Patients

BACKGROUND: No consensus exists regarding the early use of subcutaneous (SC) basal insulin facilitating the transition from continuous intravenous insulin infusion (CIII) to multiple SC insulin injections in patients with severe hyperglycemia other than diabetic ketoacidosis. This study evaluated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Yejee, Ohn, Jung Hun, Jeong, Joo, Ryu, Jiwon, Kim, Sun-wook, Cho, Jae Ho, Park, Hee-Sun, Kim, Hye Won, Lee, Jongchan, Kim, Eun Sun, Kim, Nak-Hyun, Jo, You Hwan, Jang, Hak Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262694/
https://www.ncbi.nlm.nih.gov/pubmed/35654578
http://dx.doi.org/10.3803/EnM.2021.1341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262694/
https://www.ncbi.nlm.nih.gov/pubmed/35654578
http://dx.doi.org/10.3803/EnM.2021.1341

Ejemplares similares